Ashley Cordova - 04 Mar 2026 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Former Chief Executive Officer
Signature
Steven Robbins, as attorney in fact for Cordova, Ashley
Issuer symbol
NVCR
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
4
Filing time
05 Mar 2026, 16:33:25 UTC
Previous filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cordova Ashley Former Chief Executive Officer C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE Steven Robbins, as attorney in fact for Cordova, Ashley 05 Mar 2026 0001822014

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Tax liability -17,638 -4% $13.30* 422,570 04 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ashley Cordova is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).